Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Oppenheimer Downgrades NeuBase Therapeutics to Perform

Oppenheimer Downgrades NeuBase Therapeutics to Perform

Oppenheimer analyst Hartaj Singh downgrades NeuBase Therapeutics (NASDAQ:NBSE) from Outperform to Perform.

October 21, 2022

1 minute read

Oppenheimer analyst Hartaj Singh downgrades NeuBase Therapeutics (NASDAQ:NBSE) from Outperform to Perform.

Crude Oil Moves Higher; General Motors Earnings Top Views

April 23, 2:31 PM

U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining more than 1% on…

May 30, 5:33 AM

H World Group Ltd (NASDAQ:HTHT) reported first-quarter FY23 sales growth of 67.1% year-on-year to RMB4.5 billion ($652 million), beating the analyst…

May 2, 9:01 AM

In the preceding three months, 6 analysts have released ratings for Shutterstock (NYSE:SSTK), presenting a wide array of…

November 25, 9:21 AM

Morgan Stanley analyst Dillon Cumming maintains Deere (NYSE:DE) with a Overweight and raises the price target from $424 to $522.